Revolution Medicines’ Pancreatic Cancer Drug Approval Confirms Microcap Propanc Biopharma’s Breakthrough Survival Results

27 Aug 2026 · 15:08 UTC

Observed price moves

PPCB-1.43%15 min after this headline
RVMD+0.54%15 min after this headline

MoveSurge carries market-moving headlines the moment they reach the wire, each one with what the price did next. We pay about $120,000 a month for the newswires behind this feed.